Cargando…
TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report
BACKGROUND: Thiamine-responsive megaloblastic anemia (TRMA) is a rare autosomal recessive inherited disease characterized by the clinical triad of megaloblastic anemia, sensorineural deafness, and diabetes mellitus. To date, only 100 cases of TRMA have been reported in the world. CASE PRESENTATION:...
Autores principales: | Li, Xin, Cheng, Qing, Ding, Yu, Li, Qun, Yao, Ruen, Wang, Jian, Wang, Xiumin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625038/ https://www.ncbi.nlm.nih.gov/pubmed/31296181 http://dx.doi.org/10.1186/s12887-019-1608-2 |
Ejemplares similares
-
Recurrent Stroke in a Child with TRMA Syndrome and SLC19A2 Gene Mutation
por: KARIMZADEH, Parvaneh, et al.
Publicado: (2018) -
Pharmacogenomics in diabetes: outcomes of thiamine therapy in TRMA syndrome
por: Habeb, Abdelhadi M., et al.
Publicado: (2018) -
Characterization of a Compound Heterozygous SLC2A9 Mutation That Causes Hypouricemia
por: Yoon, Jaeho, et al.
Publicado: (2021) -
A report of a pedigree with compound heterozygous mutations in the SLC22A5 gene
por: Zhou, Yunguo, et al.
Publicado: (2023) -
Phenotypical and Myopathological Consequences of Compound Heterozygous Missense and Nonsense Variants in SLC18A3
por: Della Marina, Adela, et al.
Publicado: (2021)